"Etwa 19.000 stationäre und 23.000 ambulante Patienten vertrauen jedes Jahr auf unser Klinikum an der Schnittstelle zwischen Thüringen, Sachsen und Sachsen-Anhalt. Mehr als 400 Babys erblicken jährlich im Klinikum das Licht der Welt. Hier kümmert sich ein engagiertes Team von ca. 1.000 Mitarbeitern um unsere Patienten in Altenburg und im Klinikbereich Schmölln. Rund um die Uhr bieten wir medizinische Versorgung auf höchstem Niveau in unseren 12 Kliniken. Eine exzellente technische Ausstattung ermöglicht die Anwendung moderner diagnostischer und therapeutischer Methoden. Genauso wichtig sind uns die freundliche Aufnahme und fürsorgliche Betreuung aller Patienten, wofür hier die besten Voraussetzungen geschaffen wurden."

During the past decade, Klinikum Altenburger Land GmbH conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Altenburger Land GmbH" #1 sponsor was "Biogen" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Technische Universität Dresden" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Altenburger Land GmbH" #1 collaborator was "Aalborg University" with 1 trials as a collaborator, "Alfried Krupp Krankenhaus" with 1 trials as a collaborator, "Azienda Ospedaliera di Perugia" with 1 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator and "Charite University, Berlin, Germany" with 1 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Altenburger Land GmbH" are "Alzheimer's Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Cardiovascular Disease" (2 trials), "Ischemic Stroke" (2 trials) and "Stroke" (2 trials). Many other conditions were trialed in "Klinikum Altenburger Land GmbH" in a lesser frequency.

Most popular intervention types in "Klinikum Altenburger Land GmbH" are "Drug" (15 trials), "Other" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "bococizumab (PF-04950615)" (2 trials), "7-day Holter ECG" (1 trials), "ASA 100 mg" (1 trials) and "Aducanumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Altenburger Land GmbH" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Altenburger Land GmbH". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Klinikum Altenburger Land GmbH, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Altenburger Land GmbH, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Klinikum Altenburger Land GmbH has several departments that took part in Clinical trials: "Department of Neurology, Kreiskrankenhaus Altenburg" - 4 trials